FDA authorization remains the decisive factor shaping trader views on JUUL flavor relaunches in the U.S. market. The agency approved only Virginia Tobacco and Menthol pods for the original JUUL system in 2025 and, on August 28, 2026, cleared the JUUL2 device along with tobacco- and menthol-flavored pods at lower nicotine strength. JUUL has publicly stated plans to file additional premarket tobacco product applications for adult-oriented flavors beyond these options. While a competitor received the first U.S. fruit-flavored authorizations in May 2026, JUUL has not yet secured similar approvals, though it has developed and introduced fruit profiles such as Mango in international markets. Any commercial U.S. relaunch before year-end hinges on the pace and outcome of pending FDA reviews.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedWhich flavors will JUUL relaunch in 2026?
Which flavors will JUUL relaunch in 2026?
NEW
Dec 30, 2026
Mango
45%
Mint
51%
Cucumber
51%
Fruit Medley
49%
Crème Brûlée
14%
$1,061 Vol.
Mango
$187 Vol.
45%
Mint
$160 Vol.
51%
Cucumber
$169 Vol.
51%
Fruit Medley
$89 Vol.
49%
Crème Brûlée
$456 Vol.
14%
This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.FDA authorization remains the decisive factor shaping trader views on JUUL flavor relaunches in the U.S. market. The agency approved only Virginia Tobacco and Menthol pods for the original JUUL system in 2025 and, on August 28, 2026, cleared the JUUL2 device along with tobacco- and menthol-flavored pods at lower nicotine strength. JUUL has publicly stated plans to file additional premarket tobacco product applications for adult-oriented flavors beyond these options. While a competitor received the first U.S. fruit-flavored authorizations in May 2026, JUUL has not yet secured similar approvals, though it has developed and introduced fruit profiles such as Mango in international markets. Any commercial U.S. relaunch before year-end hinges on the pace and outcome of pending FDA reviews.
This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
Market Opened: May 11, 2026, 9:33 PM ET
Volume
$1,061End Date
Dec 31, 2026Market Opened
May 11, 2026, 9:33 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.FDA authorization remains the decisive factor shaping trader views on JUUL flavor relaunches in the U.S. market. The agency approved only Virginia Tobacco and Menthol pods for the original JUUL system in 2025 and, on August 28, 2026, cleared the JUUL2 device along with tobacco- and menthol-flavored pods at lower nicotine strength. JUUL has publicly stated plans to file additional premarket tobacco product applications for adult-oriented flavors beyond these options. While a competitor received the first U.S. fruit-flavored authorizations in May 2026, JUUL has not yet secured similar approvals, though it has developed and introduced fruit profiles such as Mango in international markets. Any commercial U.S. relaunch before year-end hinges on the pace and outcome of pending FDA reviews.
This market will resolve to "Yes" if JUUL commercially relaunches the specified flavor in the United States between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
Volume
$1,061End Date
Dec 31, 2026Market Opened
May 11, 2026, 9:33 PM ETResolver
0x65070BE91...FDA authorization remains the decisive factor shaping trader views on JUUL flavor relaunches in the U.S. market. The agency approved only Virginia Tobacco and Menthol pods for the original JUUL system in 2025 and, on August 28, 2026, cleared the JUUL2 device along with tobacco- and menthol-flavored pods at lower nicotine strength. JUUL has publicly stated plans to file additional premarket tobacco product applications for adult-oriented flavors beyond these options. While a competitor received the first U.S. fruit-flavored authorizations in May 2026, JUUL has not yet secured similar approvals, though it has developed and introduced fruit profiles such as Mango in international markets. Any commercial U.S. relaunch before year-end hinges on the pace and outcome of pending FDA reviews.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions